Ultragenyx Pharmaceutical reported $352.49M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 400.41M 25.27M
Agios Pharmaceuticals AGIO:US USD 1.1B 50.64M
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Aptinyx Inc APTX:US USD 48.79M 13.31M
Biocryst Pharmaceuticals BCRX:US USD -294597000 51.94M
Biomarin Pharmaceutical BMRN:US USD 4.6B 34.64M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Esperion Therapeutics ESPR:US USD -323778000 29.68M
Insmed INSM:US USD 87.95M 117.91M
Karyopharm Therapeutics KPTI:US USD -16656000 123.62M
Kyowa Hakko Kirin 4151:JP JPY 762.83B 2M
Macrogenics MGNX:US USD 142.01M 19.06M
Mirati Therapeutics MRTX:US USD 996.52M 132.54M
Moderna Inc MRNA:US USD 19.12B 1.13B
Neurocrine Biosciences NBIX:US USD 1.71B 163.2M
Ptc Therapeutics PTCT:US USD -347086000 120.18M
Puma Biotechnology PBYI:US USD 21.61M 547K
Regeneron Pharmaceuticals REGN:US USD 22.66B 1.23B
Sarepta Therapeutics SRPT:US USD 384.95M 45.89M
Ultragenyx Pharmaceutical RARE:US USD 352.49M 116.34M
Vertex Pharmaceuticals VRTX:US USD 13.91B 883.1M
Vital Therapies VTL:US USD 113.68M 4.87M